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1. Introduction 
Fifteen percent of women treated for breast cancer with total mastectomy receive immediate 
or early breast reconstruction [1, 2]. The percentage is higher in young women and those 
treated in tertiary care medical centers. Immediate breast reconstruction (IBR) has several 
advantages [3, 4]. It can prevent some of the negative psychological and emotional sequelae 
seen with mastectomy. The aesthetic results of immediate reconstruction are superior to 
those seen after delayed reconstruction. IBR also reduces hospital costs by reducing the 
number of procedures and length of hospitalization. Immediate breast reconstruction has 
the potential to impact the treatment of breast cancer. It could affect the delivery of adjuvant 
therapy and the detection and treatment of recurrent disease. Chemotherapy and radiation 
therapy could also impact the complication rates of reconstruction. The oncological 
considerations of breast reconstruction are outlined in this chapter. 
2. Local recurrence after skin sparing and nipple sparing mastectomy 
Women with breast cancer who undergo immediate breast reconstruction do not have a worse 
survival than those not undergoing breast reconstructions. A review of a large National 
Cancer Institute database of 51,702 breast cancer patients identified 8,645 (16.7%) who 
underwent immediate breast reconstruction [5]. Patients treated by mastectomy and IBR had a 
lower hazard of death (HR 0.62) compared to those treated by mastectomy alone (p<0.001). 
The study was controlled for age, race, income, and tumor stage. Potential compounding 
factors like obesity, smoking, and underlying chronic disease were not accounted for.  
Skin sparing mastectomy (SSM) has markedly improved the aesthetic results of immediate 
breast reconstruction (Figure 1). Preservation of the native skin envelope and the 
inframammary fold reduces the amount of tissue necessary for reconstruction [6]. Breast 
symmetry can often be achieved without operating on the contralateral breast and the 
periareolar incisions are inconspicuous in clothes. 
There have been concerns that the skin, nipple and inframammary fold preservation reduce 
the effectiveness of total mastectomy. There is a large body of evidence that the local 
recurrences (LRs) after SSM are comparable to non-skin sparing mastectomy (Table 1) [7-9]. 
Care must be taken however, in patients with superficial cancers or diffuse DCIS to assure 
adequate surgical margins.  
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(a) 
 
(b) 
Fig. 1. (a) Preoperative photograph (b) Postoperative photograph after skin sparing 
mastectomy and TRAM flap reconstruction 
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Author 
Followup 
(Months) 
SSM 
(N) 
LR in SSM 
(%) 
Non-SSM 
(N) 
LR in Non-SSM 
(N) 
Newman [81] 50 437 6.2 437 7.4 
Carlson [7] 41.3 187 4.8 84 9.5 
Kroll [8] 72 114 7.0 40 7 
Simmons [9] 15.6-32.4 77 3.9 154 3.2 
Rivadeneira [82] 49 71 5.6 127 3.9 
Medina-Franco [83] 73 176 4.5 - - 
Carlson [84] 64.6 565 5.5 - - 
Slavin [85] 44.8 51 3.9 - - 
Toth [86] 51.5 50 0 - - 
Spiegel [87] 117.6 221 4.5 - - 
Foster [88] 49.2 25 4.0 - - 
SSM skin sparing mastectomy 
LR local recurrence 
Non-SSM non skin sparing mastectomy 
Table 1. Published series of local recurrence of breast cancer after skin sparing and non-skin 
sparing mastectomy 
Nipple sparing mastectomy (NSM) is growing in popularity because of its perceived 
aesthetic benefits (Figure 2). Patient satisfaction with nipple-areolar reconstruction following 
SSM can be disappointing [10]. Data regarding the oncological safety of NSM is hampered 
by small sample size, varying indications and surgical techniques, and short follow-up 
(Table 2). There are limited oncological and reconstructive indications to perform NSM. 
Large tumors and those located in the central breast have an increased incidence of nipple 
involvement. Larger, more ptotic breasts are not good candidates for the procedure. Nipple 
elevation cannot be achieved without preservation of a dermoglandular pedicle which 
impacts the completeness of mastectomy. The ideal candidate for a NSM has small to 
moderate sized breasts with minimal ptosis.  
3. Detection of local recurrence after breast reconstruction 
The role of postreconstruction imaging after the treatment of breast cancer remains 
controversial. There is a paucity of data that addresses the issue and there no established 
guidelines [11]. The incidence of local recurrence of breast cancer is related to tumor stage. 
Most LRs after total mastectomy are in the skin and subcutaneous tissue and are readily 
detected by physical examination [12]. A flap or implant could potentially delay the 
discovery of chest wall recurrences. 
Systemic relapse is not inevitable following local recurrence, especially after the treatment of 
DCIS [13, 14]. This argues that early detection of local recurrences may have a potential 
survival impact. All forms of mastectomy leave residual breast tissue. The differences are in 
terms of the microscopic breast tissue left behind in the skin and inframammary fold which 
are largely preserved after SSM. Torresan et al evaluated residual glandular tissue in the 
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skin flaps that would have been preserved after SSM [15]. They found that 60% contained 
residual glandular tissue and it correlated with skin flap thickness. 
 
(a) 
 
(b) 
Fig. 2. (a) Preoperative photograph (b) Postoperative photograph after nipple sparing 
mastectomy and implant reconstruction 
The completeness of mastectomy is important in the treatment of DCIS because most cases 
of recurrence represent unexcised residual disease. Several authors have reported LR of 
DCIS treated by SSM and IBR [13, 16, 17]. They found that the majority of LRs were invasive 
carcinomas. This suggests that postreconstruction mammography can have a role in the 
early detection of recurrences prior to the development of invasive carcinoma. 
Physical examination of implant reconstruction is relatively easy. There is minimal soft 
tissue covering the implant except along the inframammary fold and in the axillary tail. 
Deep chest wall recurrences are extremely unlikely because the implants are placed in the 
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submuscular plane. Conventional mammographic evaluation has limited utility because the 
implants obscure soft tissue visualization. MRI, which has been used extensively to evaluate 
the integrity of silicone gel implants, may have a role in the selective surveillance after 
implant reconstruction [18-21]. 
 
Study N LR (%) 
NAC Recurrence 
(%) 
Follow-up 
(months) 
Gerber [89] 60 6 (10) 1 (1) 101 
Caruso [90] 50 6 (12) 1 (2) 66 
Sacchini [91] 68 2 (2.9) 0 (0) 26.4 
Voltura [92] 32 2 (6.3) 0 (0) 18 
Benediktsson [93] 169 48 (28.4) 0 (0) 156 
Kim [94] 152 3 (9.1) 2 (1.3) 60 
Table 2. Local recurrences after nipple sparing mastectomy 
The sensitivity of physical examination of autologous reconstruction is lower than that seen 
with implant reconstruction. Deep chest wall recurrences often avoid detection until 
symptoms develop. Autologous reconstruction causes less impairment of mammographic 
tissue visualization [22]. Benign mammographic findings after TRAM flap reconstruction 
include fat necrosis, lipid cysts, calcifications, lymph nodes, and epidermal inclusion cysts 
(Figure 3) [23]. Breast cancer recurrences in autologous tissue reconstruction are 
mammographically similar to that of primary tumors (Figure 4) [24, 25]. Proponents of 
surveillance mammography feel that screening breast cancer patients with autologous 
reconstructions can detect nonpalpable recurrences before clinical examination.  
Helvie et al evaluated surveillance mammography in 113 patients after TRAM flap 
reconstruction [26]. Six patients underwent biopsy for suspicious mammographic findings 
and two local recurrences were detected. Two patients in the study group went on to 
develop recurrences that were detected by physical examination. There was one false-
negative mammogram resulting in a sensitivity of 67% and specificity of 98% for 
surveillance mammography after TRAM flap reconstruction.  
There is a paucity of data regarding the efficacy of MRI of the breast following autogenous 
breast reconstruction [27, 28]. Breast MRI has been shown to clearly delineate autogenous 
flaps from residual mammary adipose tissue. The absence of contrast medium uptake 
during breast MRI precludes recurrent carcinoma to a high probability. Fat necrosis in a 
TRAM flap will show early postoperative contrast enhancement but this resolves within six 
to twelve months. Rieber et al evaluated MRI of the breast in the follow-up of forty-one 
patients who had undergone autogenous tissue breast reconstruction [29]. MRI was able to 
distinguish flaps from surrounding residual breast tissue in all cases. It excluded disease 
recurrence in 4 patients with suspicious mammographic or sonographic findings. It 
returned false-positive findings in three cases. 
The potential indications for postreconstruction imaging include patients with close surgical 
margins and patients with diffuse DCIS treated by SSM. Its routine use after autologous 
reconstruction after SSM for invasive carcinoma warrants further study. The low detection 
rate and specificity does not justify the routine use of MRI in the follow-up of patients 
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postreconstruction. MRI is most useful in patients with abnormal findings on physical 
examination or mammography and ultrasound. It is also helpful to delineate the extent of 
local disease recurrence. 
 
Fig. 3. Mammographic appearance of fat necrosis in a TRAM flap reconstruction 
 
Fig. 4. Mammographic appearance of local recurrence in TRAM flap (L), opposite breast (R) 
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4. Breast reconstruction and adjuvant therapy 
4.1 Chemotherapy 
There are concerns that immediate breast reconstruction may delay the administration of 
adjuvant chemotherapy. A survey of 376 consultant breast surgeons in the United Kingdom 
and Ireland found that the majority (57%) preferred delayed reconstruction because of these 
concerns [30]. Breast reconstruction does have a high complication rate especially in patients 
who are obese, smoke tobacco, or have a history of chest wall irradiation. Alderman et al 
performed a multi-institutional study of complication rates after tissue expander or TRAM 
flap reconstruction [31]. They reported a 52% complication rate, with major complications 
occurring in 30% of patients.  
It seems logical that the high complication rate of IBR could potentially delay the 
administration of adjuvant therapy. Studies comparing onset of chemotherapy after IBR and 
control group treated with mastectomy alone have failed to show significant differences [32-
35]. Alderman et al performed a multi-institutional cohort study of 3643 breast cancer 
patients [35]. They found that IBR did not lead to an omission of adjuvant chemotherapy but 
was associated with a modest delay in initiating treatment. Wound complications after IBR 
must be treated aggressively to remove necrotic, potentially infected tissue. Patients with 
clean, open wounds can receive chemotherapy with minimal compromise in wound 
healing. These patients must be followed closely detect early signs of infection.  
Patients with locally advanced, Stage III breast cancer are generally treated with 
chemotherapy followed by total mastectomy and adjuvant radiation. The five-year survival 
is 50%-80%, and patients with a poor response to chemotherapy have an especially bad 
prognosis. It may be preferable to delay reconstruction until after mastectomy and adjuvant 
radiation in these patients. This avoids the potential problems with radiation delivery and 
the adverse effects of postmastectomy radiation therapy on immediate reconstruction. These 
issues will be discussed in detail later in the chapter. 
Neo-adjuvant chemotherapy may impact the complication rate of immediate breast 
reconstruction and delay adjuvant radiation. Mitchem et al evaluated the impact of neo-
adjuvant chemotherapy on tissue expander reconstruction [36]. Eleven (32%) of 34 
expanders required removal with infection accounting for 82% of implant losses. Deutsch et 
al reported a 55% complication rate in 31 patients after immediate TRAM flap reconstruction 
who received neo-adjuvant chemotherapy [37]. Six percent had a delay in resumption of 
chemotherapy because of complications. Sultan et al found a 14% complication rate in 21 
patients who received neo-adjuvant chemotherapy and underwent IBR [38]. The mean 
interval between surgery and resumption of chemotherapy was 19 days and there was no 
delay in any patients. Mehrara et al found that neo-adjuvant chemotherapy was an 
independent predictor of overall complications in free flap breast reconstruction [39]. 
Zweifel-Schlatter et al compared 47 patients undergoing immediate free flap breast 
reconstruction after neo-adjuvant chemotherapy with 52 patients who did not receive 
preoperative therapy and found no delay in beginning adjuvant therapy [40]. 
4.2 Radiation therapy 
Postmastectomy radiotherapy (PMRT) is increasing utilized in the adjuvant treatment of 
breast cancer. The current recommendations for PMRT include patients with 4 or more 
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positive axillary lymph nodes, locally advanced cancer, tumors 5 cm. or larger and positive 
margins. It is considered for medial quadrant tumors, tumors with lymphovascular 
invasion, and in patients with 1-3 metastatic lymph nodes. Two randomized trials have 
shown a survival benefit for post-mastectomy radiotherapy in patients with 1-3 metastatic 
lymph nodes [41, 42]. These studies were criticized because of high rate of regional failure in 
the non-irradiated group which was felt the result of inadequate axillary surgery and the 
use of non-anthracycline based chemotherapy. A survey of radiation oncologists found that 
only 58% would use PMRT in patients with 1-3 metastatic lymph nodes but 95% would 
recommend it for patients with 4 or more metastatic nodes [43]. 
There are technical problems related to irradiation of the reconstructed breast. Distortion of 
the chest wall anatomy means that radiotherapy portals need to be modified. The treatment 
is more difficult, particularly irradiating the internal mammary lymph nodes. This may 
result changing the depth of tangential fields resulting in increased volume of irradiated 
lung or heart.  Motwani et al examined the effect of immediate autologous breast 
reconstruction on the technical delivery of PMRT [44]. Two radiation oncologists reviewed 
radiotherapy plans in 110 patients. These were compared to matched controls that had 
mastectomy alone. A scoring system was used that evaluated chest wall coverage, treatment 
of the internal mammary lymph node chain, minimization of lung exposure, and avoidance 
of the heart. They found that 52% of the immediate reconstruction patients had compromise 
of their radiotherapy plans compared to 7% of controls. If coverage of the internal mammary 
lymph nodes was eliminated, 23% of the IBR group had compromised plans. M.D. 
Anderson Cancer Center recommends deflating tissue expanders prior to the administration 
of PMRT to overcome potential dosimetry compromise [45]. Most institutions feel that the 
potential interference of breast implants with can overcome with alteration in treatment 
planning. 
Radiation therapy has a negative impact on all forms of breast reconstruction. A meta-
analysis of over 1,000 patients showed that patients undergoing PMRT and breast 
reconstruction were more likely to suffer morbidity compared to patients not receiving 
PMRT [46]. It also showed that autologous reconstruction was associated with less 
morbidity than implant reconstruction when PMRT was administered.  There are three 
clinical scenarios that are encountered: immediate reconstruction in patients, who have 
received preoperative radiation, delayed reconstruction after PMRT, and immediate 
reconstruction in patients who will receive PMRT. Berry et al, reviewed 1037 cases of 
immediate breast reconstruction (expander 559 and autologous 478) [47]. Radiation 
whether administered preoperatively or postoperatively significantly increased the 
complication rate in expander reconstruction but had no significant impact on autologous 
reconstruction.  
Chest wall irradiation after expander / implant reconstructions results in an increase 
incidence of capsular contraction and implant exposure. Because of this, many authors feel 
that implant reconstruction is contraindicated when postmastectomy radiation is planned. 
Krueger et al performed a prospective evaluation of tissue expander reconstruction in 81 
patients, including 19 patients who received radiation [48]. Patients receiving radiation had 
a two fold increase in complications (p=0.006) and a four fold increase in reconstruction 
failure (p=0.005). The addition of autologous tissue such as the latissimus flap may reduce 
the risk of complications seen with the use of implants in the setting of radiation [49].  
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Radiation also has a deleterious effect on TRAM flap reconstruction as evidenced by 
increased incidence of fibrosis, fat necrosis, and revisional surgery [50-52]. There is an 
unpredictable volume, contour, and symmetry loss that is seen with pedicled TRAM flaps, 
free TRAM flaps, and DIEP flaps. Tran et al reviewed the M.D. Anderson Cancer Center 
experience of TRAM flap irradiation [52]. The review included 41 TRAM flaps (free TRAM 
32, pedicled TRAM 9). Ten patients (24%) required an additional flap to correct radiation 
induced contracture. Nine patients (22%) maintained normal breast volume and palpable fat 
necrosis was noted in 34% of flaps. The paper by Rogers and Allen has demonstrated similar 
deleterious effects of radiation on DIEP flap reconstruction [51]. They reported a 23.3% 
incidence of fat necrosis in the radiated group vs. 0% incidence in the control group. 
Radiation fibrosis was seen in 56.7% of cases with 5 (16.7%) requiring surgical revision.  
5. The treatment of local recurrence after breast reconstruction 
Surgical options following LR after breast reconstruction depend on the location and 
number of metastatic deposits and previous treatment. Imaging of the reconstructed breast 
and body scans are necessary to delineate the extent of tumor involvement (Figure 4). 
Isolated local recurrences can be treated with removal of as much reconstructed tissue as 
necessary to achieve negative margins. Adjuvant chest wall radiation is usually 
administered (Figure 5).  
In cases of implant reconstruction, it may be necessary to remove a portion of the implant 
capsule necessitating implant removal in some cases [53]. Howard et al reviewed 16 cases of 
LR after TRAM flap reconstruction [54]. Eight recurrences occurred in the skin and were 
detected on physical examination. Eight recurrences occurred in the chest wall and were 
symptomatic, being detected on physical examination or diagnostic imaging. Twelve were 
felt amenable to surgical resection and three required removal of the entire TRAM flap. 
6. Oncological considerations in partial mastectomy reconstruction 
Oncoplastic surgery combines the principles of oncologic surgery (breast conserving 
therapy) and plastic surgery (breast reconstruction). It has the potential for better tumor free 
margins and enhancement of the cosmetic outcome [55]. Reconstruction can be performed 
via parenchymal rearrangement or volume replacement with local or distant flaps [56, 57]. 
Studies suggest these techniques are associated with low local recurrence but the long term 
oncological safety of these procedures is not clearly defined [58]. Young patients, especially 
those with diffuse high grade DCIS; do not appear to be good candidates because of the 
increase in margin involvement and LR. Follow-up mammographic evaluation does not 
appear to be significantly impacted by onco-plastic reconstruction.   
6.1 Sentinel lymph node biopsy and breast reconstruction 
Sentinel lymph node biopsy has replaced axillary dissection as the standard of care for 
axillary node sampling. The sensitivity of intraoperative pathological SLN analysis is 68%-
91% [59-61]. It is related to the size of the metastatic deposits which is related to tumor size. 
False negative intraoperative diagnoses of sentinel lymph node metastases present unique 
problems in breast cancer patients after immediate breast reconstruction. The standard of 
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care for patients with tumor positive SLNs is a completion axillary lymph node dissection. 
This procedure can be technically demanding if a latissimus dorsi flap reconstruction has 
been performed or the thoracodorsal vessels have been used for microvascular 
reconstruction [62]. Fortunately, the internal mammary vessels have become the vessels of 
choice for microsurgical breast reconstruction. They are easier to access and permit early 
postoperative arm mobilization without risk of injury to the flap vascular pedicle. Vessel 
location facilitates placement and the latissimus dorsi muscle blood supply is preserved if 
salvage surgery is necessary. Internal mammary lymph nodes can sometimes be 
encountered at the time of vessel dissection [63]. Involvement of these lymph nodes has 
prognostic significance and should be biopsied when they are discovered.   
 
(a) 
 
(b) 
Fig. 5. (a) Photograph tissue expander reconstruction of the right breast immediately after 
completing radiation (b) Appearance 12 months after completing radiation 
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A few studies have suggested SLN biopsy prior to mastectomy and IBR to avoid potential 
complications seen with PMRT [64-66]. This could facilitate decision making regarding 
immediate breast reconstruction and avoid a second operation in cases of FNG SLN 
biopsies. McGuire et al found that SLN biopsy before mastectomy and IBR changed the 
operative strategy in 62% of patients [67]. 
7. Contralateral prophylactic mastectomy 
More women are choosing to have a contralateral prophylactic mastectomy (CPM) at the 
time of treatment of their unilateral breast cancer. Tuttle et al used SEER data to evaluate the 
treatment of unilateral breast cancer from 1998-2003 [68]. They found the rate of CPM in 
women undergoing total mastectomy more than doubled in the six year period. The use of 
CPM is associated with younger patient age, a family history of breast cancer, the use of 
immediate breast reconstruction, the use of breast MRI at the time of diagnosis, non-
invasive histology, and prior attempts at breast conservation [68-73].  
Contralateral prophylactic mastectomy at the time of total mastectomy and IBR has two 
main advantages: it reduces the risk of developing a new cancer and it facilitates breast 
reconstruction. Women with unilateral breast cancer have an increased risk of developing a 
second cancer in the contralateral breast. The annual incidence of new breast cancer has 
been reported to be 0.7% - 1.8% [74-76]. Adjuvant hormonal therapy has been shown to 
reduce this risk. Despite the high incidence of cancer development, most patients will not 
experience a survival benefit from a CPM. The risk of systemic metastases from the index 
cancer exceeds the risk of contralateral cancers, which tend to be lower in stage. Younger 
women with stage I and II estrogen receptor negative cancer have been shown to benefit 
from CPM [70]. 
The Society of Surgical Oncology updated their position statement on prophylactic 
mastectomy in 2007 [77]. It detailed potential indications in patients with current or 
previous diagnosis of breast cancer to include: 
 Patients at high risk of contralateral breast cancer (BRCA mutation, strong family 
history) 
 Patients with mammographically dense breasts or those with diffuse indeterminate 
microcalcifications 
 Patients with unilateral breast cancer treated by total mastectomy and IBR who desire 
improved symmetry or have a desire for bilateral reconstruction 
A CPM and bilateral reconstruction is especially useful in cases of implant based 
reconstruction (Figure 6). The contralateral breast frequently requires remedial surgery to 
achieve symmetry with an implant reconstructed breast. Clough et al found that the 
cosmetic outcome of unilateral implant reconstruction deteriorated with time [78]. They 
attributed this asymmetry largely to ptosis of the native breast seen with aging. Bilateral 
reconstruction would prevent this asymmetry development.  
The majority of women are satisfied with their decision to undergo CPM [79]. The most 
common reasons for regret appear to be poor cosmetic outcome and a diminished sense of  
sexuality [80]. 
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(a) 
 
(b) 
Fig. 6. (a) Photograph after left TRAM flap reconstruction (b) Appearance 12 months after 
completing radiation. 
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